Tech Company Financing Transactions
TwoStep Therapeutics Funding Round
2048 Ventures, Insight Venture Partners and M Ventures joined a $62.5 million Series A venture round for TwoStep Therapeutics. This venture round closed on 9/9/2026.
Transaction Overview
Company Name
Announced On
9/9/2026
Transaction Type
Venture Equity
Amount
$62,500,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead multi-specific peptide-drug conjugate, TS-104, through Phase 1 clinical development in oncology, advance its radioligand program, and expand into new peptide conjugates.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
733 Industrial Road
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
TwoStep Therapeutics is pioneering a multi-targeting platform to advance a pipeline of targeted therapies that are broadly applicable across solid tumors. With this approach, the company aims to transform cancer treatment by extending precision medicines to more diverse tumor types and patient populations, for which few options exist.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Caitlyn Miller
Co-Founder
Carolyn Bertozzi
Co-Founder
Jennifer Cochran
Co-Founder
Ronald Levy
VP - Bus. Development
Michael Ostrach
Browse more venture capital transactions:
Prev: 9/9/2026: ClaimQI venture capital transaction
Next: 9/9/2026: Cylake venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs